Home Biosimilar Antibodies Others Others antibody Concizumab (Anti-TFPI) For research use only.
Not for use in humans.

Concizumab (Anti-TFPI)

Synonyms: NN 7415, mAb 2021, Anti-TFPI Recombinant Antibody

Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.

Concizumab (Anti-TFPI)

Purity & Quality Control

Biological Activity

Description Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.

Product Details

CAS No. 1312299-39-0
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Concizumab (Anti-TFPI) | Concizumab (Anti-TFPI) supplier | purchase Concizumab (Anti-TFPI) | Concizumab (Anti-TFPI) cost | Concizumab (Anti-TFPI) manufacturer | order Concizumab (Anti-TFPI) | Concizumab (Anti-TFPI) distributor